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Abstract
The standard practice during the third stage of labour of Dutch midwives and obstetricians was elucidated by a questionnaire 
mailed to all Dutch midwives and obstetricians. Prophylactic oxytocics in the third stage are used as a routine by 55% of the 
obstetricians and only 10% of the midwives. Oxytocin is the drug of first choice. Conclusion; Routine use of prophylactic oxytocics 
in the third stage is not the standard practice in the Netherlands. Obstetricians are much more likely to use prophylaxis than 
mid wives.
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The World Health Organization (WHO) advocates 
prophylactic oxytocic drugs to be administered to all 
women in the third stage of labour to reduce postpartum 
blood loss [1], A survey in the United Kingdom in 1984 
showed that active management with Syntometrine (a 
combination of oxytocin and ergometrine) and controll­
ed cord traction is universal in units with a third stage
management policy, i.e. 98% of all units [2,3].
The situation in the Netherlands is different in that 
there exists a strong belief that expectant management in 
low-risk women is not worse than active management. 
Also other studies in Ireland [4] and the United 
Kingdom [5] suggest that there still exists a need for a 
trial of oxytocin vs. placebo in women at low risk for 
postpartum haemorrhage. To elucidate standard prac­
tice during the third stage of labour in the Netherlands, 
we mailed a questionnaire to all Dutch midwives and 
obstetricians. We here report the results of a question­
naire sent to all Dutch midwives and obstetricians to in­
vestigate the practices followed during the third stage of 
labour.
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They were asked whether they routinely, on indica­
tion, or never used prophylactic oxytocics in the third
stage of labour; whether they used oxytocin, ergo­
metrine, or prostaglandins as first, second or third 
choice; and which dose of oxytocin (1 or 5 or 10IU) they 
used.
Of 1394 mid wives, 406 (29%) returned the question­
naire. For the obstetricians, the response rate was 
higher: 47% responded (401 of the 855). The overall re­
sponse rate was 35%.
Fifty-five percent of the obstetricians use prophylactic 
oxytocics in the third stage as a routine; the other 45% 
only do so when indicated. For the obstetricians the 
drug of first choice was oxytocin (98.5%). Ergometrine 
was used as second choice (49%), and prostaglandins 
were used as third choice drug (29%). Only 10% of the 
midwives use prophylactic oxytocics in the third stage as 
a routine. Of the midwives, 98.5% use oxytocin as the 
drug of first choice; ergometrine is second choice (46%) 
while prostaglandins were used by 2% as the third 
choice. The most frequently used dose was 5 IU of oxy­
tocin; routine use of prophylactic oxytocics in the third 
stage of labour is not the standard of practice in the 
Netherlands as is shown in Fig. 1.
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Fig. 1. Use of oxytocic drugs in the third stage of labour in the 
Netherlands,
The overall response rate of 35% is fairly good for 
pharmaceutical mailing, but selection of responders
might take place. It is unknown which obstetrians or 
midwives responded and therefore bias may have oc­
curred. The difference in management between obstetri­
cians and midwives (55% vs. 10% used prophylactic
oxytocics a routine) is so large, however, that the survey 
supports the statement that there are big differences be­
tween obstetricians and midwives in the management of 
the third stage of labour.
It is unlikely that those midwives not responding, all 
routinely use prophylactic oxytocics. As for the obstetri­
cians we only cautiously can say that there is no consen­
sus. The differences between those using prophylactic 
oxytocics as a routine and those doing so on indication 
are too small and might change when the response rate 
on the questionnaire would have been larger.
We conclude that in the Netherlands, routine pro­
phylactic oxytocics is not the standard practise as is the 
case in the United Kingdom. The Netherlands, 
therefore, is one of the few places where one can still 
conduct randomised trials of oxytocics with a placebo.
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